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ABSTRACT
In the last years, RNA interference (RNAi)-mediated
gene knockdown has developed into a routine
method to assess gene function in cultured mam-
malian cells in a fast and easy manner. For the use
of this technique in developing or adult mice, short
hairpin (sh)RNA vectors expressed stably from the
genome are a faster alternative to conventional
knockout approaches. Here we describe an
advanced strategy for conditional gene knockdown
in mice, where we used the Cre/loxP system to
activate RNAi in a time and tissue dependent
manner in the adult mouse brain. By placing
conditional RNAi constructs into the defined geno-
mic Rosa26 locus and by using recombinase
mediated cassette exchange (RMCE) instead of
laborious homologous recombination, we devel-
oped a fast, easy and reproducible approach to
assess gene function in adult mice. We applied this
technique to three genes of the MAPK signaling
pathway—Braf, Mek1 and Mek2—and demonstrate
here the potential of this new tool in mouse
mutagenesis.
INTRODUCTION
RNA interference (RNAi) has become an extremely useful
genetic tool to study gene function in mammalian cells.
The discovery that short double-stranded RNAs, known
as short interfering (si)RNAs, avoid an interferon
response and the global shutdown of translation has
enabled the wide use of transient gene silencing in cultured
cells and specific tissues of mice upon local administration
(1). To elicit permanent gene silencing, short hairpin
(sh)RNA expression vectors can be used. These vectors
consist of an RNA polymerase III promoter producing
short RNA fragments, which form hairpin structures.
These shRNAs are processed by the RNAi machinery in
the same way as linear double-stranded RNAs such that
sequence-specific gene silencing occurs (2). Mice trans-
genic for shRNA vectors produce an all-over knockdown
phenotype, similar to conventional knockout mice (3).
To overcome the embryonic lethality of many mutants
and to investigate gene functions in specific tissues or in a
time dependent manner, conditional vectors have to be
used. ShRNA expression can either be regulated by an
inducing compound-like doxycycline acting on artificial
regulatory sequences in the polymerase III promoter (4) or
shRNA production is blocked by a transcriptional stop
element that can be deleted through Cre mediated
recombination. The latter Cre/loxP approach is similar
to conditional knockout or knock in strategies where it is
widely used. Various vector designs for Cre/loxP regulated
RNAi have been described (5,6). Here, we show a fast and
highly reproducible system to generate mice expressing
shRNAs under the control of Cre recombinase. This tool
can be applied to a great variety of biological questions
since a large collection of mouse strains that express
Cre recombinase in specific cell types is available and
can be used to activate conditional shRNA vectors at
different developmental stages and in selected cell types of
mice (7).
Mitogen activated protein kinases (MAPKs), also called
extracellular signal-regulated kinases (ERKs), are a group
of serine/threonine terminal protein kinases evolutionarily
conserved from yeast to human. They form an intracel-
lular signaling cascade regulating fundamental cellular
functions including proliferation, cell survival and differ-
entiation (8). The MAPK pathway plays also an
important role in neurons as it is involved in synaptic
plasticity, neuronal survival and regeneration (9).
A regulatory function of MAPK signaling for anxiety
and depression-like behavior of adult mice has been
proposed (10) but not tested with genetic models in vivo.
Here, we show that a conditional knockdown of Braf and
Mek1 andMek2 in the adult murine brain is possible with
our RNAi approach, which gives the possibility to test the
role of these genes in anxiety and depression-like behavior
in vivo.
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MATERIALS AND METHODS
LacZ and Luciferase shRNA vectors
H1 promoter vectors. The human H1 promoter was
recovered as 119 bp SalI/KpnI fragment from the plasmid
H1-RasGap (3) and ligated into the SalI/KpnI sites of
pNEB193 (New England Biolabs). Plasmid H1-shLacZ
coding for a lacZ specific shRNA was obtained by ligation
of an oligonucleotide pair (50-cccctggcgttacccaacttaatc
gaagcttggattaagttgggtaacgccagggtttttggaaag-30, 50-aattctt
tccaaaaaccctggcgttacccaacttaatccaagcttcgattaagttgggtaacg
ccagggggtac-30; targeting nt 57–79 of E.coli lacZ gene)
into the KpnI/EcoRI sites of pNEB-H1. pNEB-
H1-shLacZ was opened with PsiI/KpnI and ligated with
an oligonucleotide pair (50-taacttcgtatagcatacattatacgaagt
tatggtac-30, 50-cataacttcgtataatgtatgctatacgaagtta-30) to
create H1-shLacZ-loxP1 or opened with KpnI and ligated
with another oligonucleotide pair (50-ataacttcgtatagcatac
attatacgaagttatatatactagtcgacgtac-30, 50-gtcgactagtatatat
aacttcgtataatgtatgctatacgaagttatgtac-30) to create
H1-shLacZ-loxP3. To create H1-shLacZ-lox2, that con-
tains a lox2272 sequence (11), pNEB-H1-shLacZ was
opened with SalI/KpnI and ligated with a 120 bp DNA
fragment from an oligonucleotide pair (50-acgcgtcgacg
gatcgggagatccaatatttgcatgtcgctatgtgttctgggaaatcaccataaac
gtgaaatata-30, 50-ggggtaccgagtggtctcaataacttcgtataaggtatc
ctatacgaagttatatttcacgtttatggtgattt-30) that was annealed,
extended with Klenow polymerase, and digested with SalI/
KpnI. Upon removal of a 50 HindIII site from H1-shLacZ
by SapI/PmeI digestion, end filling and religation,
H1-shLacZ was opened within the shRNA loop region
by HindIII and ligated with an oligonucleotide pair
(50-agctataacttcgtatagcatacattatacgaagttatggatcc-30, 50-agc
tggatccataacttcgtataatgtatgctatacgaagttat-30) to create
H1-shLacZ-loxP4 or with an other oligonucleotide pair
(50-agctataacttcgtatagcatacattatacgaagttat-30, 50-agctata
acttcgtataatgtatgctatacgaagttat-30) to obtain H1-shLacZ-
loxP5.
U6 promoter vectors. The pSHAG plasmid containing the
human U6 promoter (12) was opened with BseRI/BamHI
and ligated with a lacZ specific shRNA oligonucleotide
pair (50-gcgttacccaacttaatcgccttggaagcttgcaaggcgattaagt
tgggtaacgccttttttggaaa-30, 50-gatctttccaaaaaaggcgttacccaac
ttaatcgccttgcaagcttccaaggcgattaagttgggtaacgccg-30; target-
ing nt 61–85 of E. coli lacZ gene) to generate U6-shLacZ
or ligated with a humanized F-Luciferase specific shRNA
oligonucleotide pair (50-tgcgctgctggtgccaacgaagcttggttgg
caccagcagcgcacttttttggaaa-30, 50-gatctttccaaaaaagtgcgctgct
ggtgccaaccaagcttcgttggcaccagcagcgcacg-30) to generate
U6-shLuc. To create U6-shLacZ-loxP3, the U6-shLacZ
segment was recloned into a modified pBluescript plasmid,
opened with SgrAI at the transcriptional start site and
ligated with an oligonucleotide pair (50-ccggataacttcgtata
gcatacattatacgaagttatatatactagtcgac-30, 50-ccgggtcgactagta
tatataacttcgtataatgtatgctatacgaagttat-30). For U6-shLacZ-
loxP4, U6-shLacZ was opened in the shRNA loop region
with HindIII and ligated with a pair of oligonucleotides
(50-agctataacttcgtatagcatacattatacgaagttatggatcc-30, 50-agc
tggatccataacttcgtataatgtatgctatacgaagttat-30) that intro-
duce a loxP sequence and a 50 BamHI site. For
U6-shLacZ-loxP5, U6-shLacZ was opened with HindIII
and ligated with a pair of oligonucleotides (50-agctata
acttcgtatagcatacattatacgaagttat-30, 50-agctataacttcgtataatg
tatgctatacgaagttat-30) that inserts a loxP sequence into the
shRNA loop in a symmetric fashion.
To generate the conditional lacZ and Luciferase
specific shRNA vectors U6-lox-lox-shluc and U6-lox-
lox-shLacZ, plasmids U6-shLuc and U6-shLacZ were
opened in the loop region with HindIII, the ends were
filled with Klenow fragment and ligated with a 338 bp
MlyI fragment serving as loxP flanked stop cassette. This
MlyI fragment was cut from a pNEB193 based vector
that contained a 19 bp R-Luciferase antisense and two
polythymidine sequences, serving as termination signals,
and that has been flanked with loxP sequences from
oligonucleotide pairs that were ligated into the HindIII
site (50-agctgagtcgactgataacttcgtatagcatacattatacgaagttat
ggatcc-30, 50-agctggatccataacttcgtataatgtatgctatacgaagtt
atcagtcgactc-30) and NdeI site (50-tattttttggatccataacttcgt
atagcatacattatacgaagttatgactggactc-30, 50-tagagtccagtcat
aacttcgtataatgtatgctatacgaagttatggatccaaaaaa-30). The
sequence of the 338 bp stop cassette fragment is (loxP-
sites underlined): 50-ataacttcgtatagcatacattatacgaagttatgg
atccagcttggtagcgcggtgtattatactttttggaaagaattcactggccgtcgt
tttacaacgtcgtgactgggaaaaccctggcgttacccaacttaatcgccttgcag
cacatccccctttcgccagctggcgtaatagcgaagaggcccgcaccgatcgccc
ttcccaacagttgcgcagcctgaatggcgaatggcgcctgatgcggtattttctcc
ttacgcatctgtgcggtatttcacaccgcatattttttggatccataacttcgtatag
catacattatacgaagttat-30.
To delete the loxP flanked stop cassette from U6-lox-
lox-shluc and U6-lox-lox-shLacZ, the plasmids were
transformed into Cre expressing bacteria (294cre; 13)
and recombined subclones (U6-loxP5-shLuc, U6-loxP5-
shLacZ) were retransformed into E. coli strain DH5a. All
plasmids were grown in DH5a, isolated with Qiagen
plasmid Maxiprep columns and the integrity of the
promoter and shRNA regions was confirmed by DNA
sequencing.
Braf andMek1/2 shRNA vectors
The pSHAG plasmid containing the human U6 promoter
(12) was opened with BseRI/BamHI and ligated with a
Braf specific shRNA oligonucleotide pair (50-gagaggagttac
atgttgaagaagcttgttcaacatgtaactcctctccttttttggaaa-30, 50-gat
ctttccaaaaaaggagaggagttacatgttgaacaagcttcttcaacatgtaact
cctctccg-30, targeting 50-ggagaggagttacatgttgaag-30 in Braf
Exon 5) to generate pU6-shBraf or ligated with a Mek1/2
specific shRNA oligonucleotide pair (50-acggcgagatcagca
tctgcatgaagcttgatgcagatgctgatctcgccgtcttttttggaaa-30, 50-
gatctttccaaaaaagacggcgagatcagcatctgcatcaagcttcatgcagatg
ctgatctcgccgtcg-30, targeting 50-gacggcgagatcagcatctgc
atg-30 in Mek1 Exon 2 and Mek2 Exon 2) to generate
pU6-shMek1/2. To create pU6-shBraf-flox and pU6-
shMek1/2-flox, the vector pU6-shBraf or pU6-shMek1/2,
respectively, was opened with HindIII in the loop region
of the hairpin sequence, ends were filled with Klenow
fragment, followed by ligation with the above described
MlyI fragment containing the loxP-flanked stop cassette.
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Tissue culture
Mouse F1 ES cells (IDG3.2) were used for transient and
stable transfections. Cells were grown in DMEM medium
(Gibco) containing 15% fetal calf serum, 20mM HEPES,
1 non-essential aminoacids, 0.1mM b-mercaptoethanol
and 1.5 103U/ml leukemia inhibiting factor on gelatin
coated culture dishes for transient transfections or on
mitomycin c treated embryonic fibroblasts for stable
transfections and blastocyst injections.
Transient transfections
Transient transfections with the lacZ and Luciferase
specific shRNA vectors were performed with Fugene6
transfection reagent following the manufacturer’s proto-
col (Roche Diagnostics). One day before transfection
60 000 ES cells were plated into each well of a 24 well
culture plate. 150 ng of each supercoiled plasmid, a total
amount of 450 ng, were complexed with 2 ml Fugene and
transfected in duplicate into each well in 500 ml growth
medium. For b-Galactosidase and Luciferase measure-
ments 150 ng of the b-Galactosidase expression vector
CMVb (Promega) were transfected together with 150 ng
shRNA vector and 150 ng of the F-Luciferase expression
vector pCMV-hLuc. pCMV-hLuc was generated by
ligation of the CMV promoter (770 bp XhoI/EcoRI
fragment) from pUHD17-1 (14) into the XhoI/HindIII
sites of pGL3 basic (Promega) that contains a codon
optimized F-Luciferase gene. The medium was changed
after 24 h and the cells were lysed and chemiluminescence
was detected 48 h after transfection.
Chemiluminescence reporter gene assays
The preparation of lysates and measurement of
b-Galactosidase activity were performed with the
b-Galactosidase analysis kit (Roche Diagnostics) follow-
ing the manufacturer’s protocol. Fifty microliter of freshly
prepared lysates were measured for 5 s in an Orion I plate
luminometer (Berthold). For the detection of F-Luciferase
activity, 20 ml of each lysate were mixed with 100 ml
Luciferase assay buffer (25mM glycylglycine, KH2PO4,
4mM EGTA, 2mM ATP, 1mM DTT, 100 mMCoenzyme
A, 75 mM Luciferin, pH8) and measured for 5 s in the
Orion I plate luminometer.
For lacZ shRNA vectors, the relative light units (RLU)
from b-Galactosidase measurements were normalized to
the Luciferase RLU of each sample, and for Luciferase
shRNA vectors, RLU from b-Galactosidase were used for
normalization. The measurements of b-Galactosidase
RLU in Rosa26.5/26.9 ES cells were normalized to
the total amount of protein in the lysates. Protein
determinations were performed with the BCA
protein assay kit (Pierce) following the manufacturer’s
instruction.
Homologous recombination into Rosa26
The Rosa26 gene targeting vector pRosa26.5 was
assembled from Rosa26-1 (15) by insertion of a splice
acceptor element (16), the b-Galactosidase (lacZ) coding
region and polyA signal from CMVb (Promega), and the
hygromycin resistance gene cassette from plasmid pgk-
hygro-pA (a gift from P. Krimpenfort) into the XbaI site.
The Rosa26 gene targeting vector pRosa26.9 was
assembled from Rosa26-1 by insertion of a splice acceptor
element, a SV40 late polyA signal, a neomycin resistance
cassette from pgk-neo-pA (a gift from P. Soriano) and the
conditional shRNA vector U6-lox-lox-shLacZ into the
XbaI site; further details on cloning are available on
request. The linearized vectors were electroporated into
mouse F1-ES cells followed by selection with G418
(140mg/ml) or hygromycin (125U/ml) for 7 days.
Resistant colonies were analyzed by Southern blotting of
EcoRV digested genomic DNA using the Rosa26
50-probe. One of the Rosa26.5 ES cell clones was further
transfected with pRosa26.9 to introduce the conditional
shRNA vector into the second Rosa26 locus.
The Rosa26 50-probe for Southern blotting is a 448 bp
fragment of the Rosa26 locus 50 to the first exon, amplified
with the following primer pair: 50-aaggatactggggcatacg-30
and 50-cttctcagctacctttacacacc-30. With this probe, recom-
bined Rosa26.5 ES cell clones were recognized by the
presence of a 3.6 kb fragment in addition to the 11.5 kb
Rosa26 wild type band after EcoRV digestion.
Recombined Rosa26.9 ES cell clones were recognized by
the presence of a 3.1 kb fragment in addition to the 3.6 kb
Rosa26.5 band; a remaining 11.5 kb wild type band
indicated a trisomy of chromosome 6 in these ES cells
(data not shown).
To activate the shRNA vector through Cre mediated
recombination, double-targeted Rosa26.5/26.9 ES cells
were transiently transfected with the Cre expression
plasmid pCAG-cre-bpA. It was generated from pgk-cre-
bpA (a gift from W. Mu¨ller) by EcoRI/PstI digestion to
remove the pgk promoter and by insertion of the CAGGS
promoter from CAGGS-FLPe (17) as a 1673 bp SalI/
AlwNI fragment. Transfected subclones were expanded
and analyzed by Southern blotting of BamHI digested
genomic DNA for Cre mediated deletion of the stop
cassette. The Rosa26 50-probe detects a 6.5 kb band from
the Rosa26.5 allele and a 5.8 kb band from the non-
recombined Rosa26.9 allele, the same size is produced by
the wild type locus. Cre mediated deletion can be
recognized by the shift of the 5.8 kb Rosa26.9 band to a
size of 9 kb since the deleted stop cassette contains a
BamHI site (data not shown).
Three non-recombined and two recombined subclones
were further expanded without feeder cells on gelatin
coated plates and analyzed for b-Galactosidase activity
by detection of chemiluminescence or by histochemical
staining of fixed cells.
b-Galactosidase staining
Cells were washed with phosphate buffered saline (PBS)
and fixed for 5 min at room temperature in 4%
paraformaldehyde in PBS. Next, the cells were washed
twice with PBS and incubated in X-Gal staining solution
(5mM K3(Fe(CN)6), 5mM K4(Fe(CN)6), 2mM MgCl2,
1mg/ml X-Gal (BioMol) in PBS) for 24 h at 378C.
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Images were taken using an AxioCam HRc camera and
the AxioVision program (Carl Zeiss).
Cassette exchange vectors
The cassette exchange acceptor vector pRosa26.10 was
assembled from Rosa26-1 (15) by insertion of a splice
acceptor sequence and a modified hygromycin resistance
gene derived from pgk-hygro-pA (a gift from P.
Krimpenfort) into the XbaI site. One 50 bp attP recogni-
tion site (50-gtagtgccccaactggggtaacctttgagttctctcagttggggg
cgtag-30) for fC31 integrase (18) was placed between the
pgk-promoter and the hygro-coding region. A second attP
site was cloned in the same orientation downstream of the
hygro-polyA region. Homologous recombination of
pRosa26.10 in ES cells was achieved as reported above
and hygromycin resistant colonies were analyzed for
homologous recombination by Southern blotting of
EcoRV digested genomic DNA using the Rosa26
5-probe (see above). Homologous recombination of the
pRosa26.10 vector is indicated by a 4.5 kb band in
addition to the 11.5 kb band from the wild type Rosa26
allele. The ES cell clone IDG26.10-3 was selected for
further work, and the ability of these cells to colonize the
germline in chimeric mice was confirmed (data not
shown).
The cassette exchange donor vector pRMCE was
assembled within the backbone of pBluescript containing
a modified polylinker region. One 53 bp attB recognition
site (50-ccgcggtgcgggtgccagggcgtgcccttgggctccccgggcgcg
tactccac-30) of C31Int was cloned upstream of the
neomycin coding and polyA region derived from pgk-
neo-bpA, and a second attB site was cloned downstream
in the same orientation. The multiple cloning site from
pBluescript was inserted as a SacI/KpnI fragment between
the polyA signal and the second attB site for subcloning of
shRNA constructs.
The expression vector pCAG-C31Int was generated by
PCR amplification of the 1900 bp coding region of fC31
integrase from phage DNA (DSM-49156 received from
DSMZ—Deutsche Sammlung von Mikroorganismen und
Zellkulturen GmbH, Braunschweig, Germany) with prim-
ers C31N (50-taagtctagaccgatatgacacaaggggttgtgaccg
gggtg-30) and C31C (50-cgactctagactaaaccttcctcttcttctta
ggcgccgctacgtcttccgtgccgtcctgg-30), digestion with XbaI
and cloning into the XbaI site of pNEB193. Primer
C31C introduces a SV40 derived nuclear localization
signal to the C-terminus of fC31 integrase as described
(19). Upon sequence confirmation, the C31Int coding
region was cloned as PacI-PstI fragment into pNEB-CAG
downstream of the CAGGS promoter resulting in pCAG-
C31Int(NLS). pNEB-CAG was generated by cloning the
CAGGS promoter as 1673 bp blunt ended SalI/AlwNI
fragment from pCAGGS-FLPe (17) into the filled BamHI
site of pNEB193. A bovine polyA region from pgk-neo-
bpA was added into the PmeI site of pCAG-C31Int(NLS)
as 300 bp XbaI/NotI fragment resulting in pCAG-
C31Int(NLS)-bpA. Further details on cloning strategies
are available on request. The sequences and maps of
pRosa26.10 and pCAG-C31(NLS)-bpA and a protocol
for cassette exchange in ES cells are available at http://
www.rnai.ngfn.de/index_4.htm.
Recombinase mediated cassette exchange
Braf and Mek1/2 shRNA constructs were cloned as NotI/
EcoRV fragment from pU6-shBraf-flox or pU6-shMek-
flox, respectively, into pRMCE to generate the shRNA
donor vector for RMCE. The donor vector was coelec-
troporated with a C31Int expression vector into mouse
acceptor ES-cells (clone IDG26.10-3) followed by selec-
tion with G418 for 7 days. Resistant colonies were isolated
and analyzed for cassette exchange by Southern blotting
of ScaI digested genomic DNA using the Rosa26 50-probe
(see above). A 9.2 kb band in addition to the 6.1 kb band
from the wild type Rosa26 locus indicated correct cassette
exchange, whereas the original RMCE locus gives rise to a
7.6 kb band.
Generation of mutant mice, breeding and genotyping
Positive ES cells containing the shBraf-flox or the shMek-
flox construct, respectively, were injected into C57BL/6
blastocysts. Resulting chimeras were bred to C57BL/6
mice and offspring were tested for germline transmission.
Heterozygous mice for the modified Rosa26 allele were
crossed to CamKII-cre and Nestin-cre mice (on C57BL/6
background), respectively (20,21), to obtain shBraf+/flox/
CamKII-cre mice and shMek1/2+/flox/Nestin-cre mice.
Experiments on animals were carried out in accordance
with national and institutional guidelines.
Cre transgenes were genotyped by PCR using the
primer pair 50-ATGCCCAAGAAGAAGAGGAAGGT-
30 and 50-GAAATCAGTGCGTTCGAACGCTAGA-30
to amplify a 447 bp fragment from the Cre gene. The
shBraf and shMek1/2 constructs in the Rosa26 locus were
genotyped by Southern blotting of EcoRV digested
genomic DNA using the Rosa26 50-probe (see above).
ShRNA-alleles are indicated by a 5.2 kb band in addition
to the 11.5 kb band of the wildtype Rosa26 allele.
Southern blotting
DNA was extracted from brain tissue with the Wizard
genomic DNA extraction kit (Promega). Ten micrograms
of genomic DNA were digested with BamHI, run on a
0.8% agarose gel and blotted on a nylon membrane
(Hybond N+, Amersham). Hybridization was performed
overnight at 658C with the Rosa26 50-probe, labeled with
32P (50-[a-32P]dCTP, Amersham). After washing, the
membrane was exposed to a Kodak BioMax MS film.
Northern blotting
Whole brains or half brains (with forebrain regions only,
for Braf) were used for RNA extraction with TriReagent
(Ambion). Northern blots for mRNA were performed
with the NorthernMax-Gly system (Ambion). Membranes
were hybridized overnight at 658C with a 32P-labeled
DNA probe (50-[a-32P]dCTP, Amersham) against the
30UTR of Mek1 or -Actin (Ambion). After washing,
the membrane was exposed to a Kodak BioMax film.
Quantification of band intensities was performed with an
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Imaging Plate and the FLA-8000 instrument (Fujifilm
Life Science). For analysis of siRNAs, forebrain regions
of shBraf+/flox/CamKII-cre and half brains of
shMek1/2+/flox/Nestin-cre were used for extraction of
small RNAs with the mirVana miRNA isolation kit
(Ambion). Two or three micrograms of small RNA were
separated on a Novex TBE-urea gel (15%, Invitrogen).
As positive control 0.05 pmol of an oligonucleotide
corresponding to the antisense region of the hairpin was
used (50-ATGCAGATGCTGATCTCGCCGTC-30 for
shMek1/2 and 50-TTCAACATGTAACTCCTCTCC-30
for shBraf). RNA was blotted onto a nylon membrane
(Hybond N+, Amersham), which was hybridized at 408C
with an oligonucleotide probe (50-GACGGCGAG
ATCAGCATCTGCAT-30 for shMek1/2 and 50-GGAG
AGGAGTTACATGTTGAA-30 for shBraf), labeled with
32P (50-[g-32P]dATP, Amersham). After washing, the
membrane was exposed to a Kodak BioMax film.
In situ hybridization
Mice were asphyxiated with CO2 and perfused intracar-
dially, after a brief rinse with ice-cold PBS, with ice-cold
4% paraformaldehyde in 0.1M phosphate buffer (PB, pH
7.5). Brains were dissected and post-fixed for 2 h in 4%
paraformaldehyde-PB. For embedding, the brains were
dehydrated through an ascending ethanol scale (30%,
50%, 70%, 95%, 2 100%, 1 h each passage), clarified in
Rotihistol (Roth) 2 45min, equilibrated in 50%
Rotihistol/50% paraffin for 1 h, and then transferred
into paraffin at +658C, 2 1 h; they were equilibrated to
room temperature in the last paraffin passage and kept at
+48C until cutting. Eight-micrometer sections were cut
coronally and mounted on SuperFrost Plus slides
(Menzel-Glaeser); slides were dried overnight at 378C
and put at +48C until proceeding with in situ hybridiza-
tion (ISH).
For preparation of the Mek1 riboprobe, a DNA
template was prepared by RT-PCR on total RNA
extracted from adult brains of C57BL/6J mice. Total
RNA was extracted using Trizol (Invitrogen) following
manufacturer’s instructions. Reverse transcription was
performed using random hexamers and SuperScriptII
(Invitrogen Kit) following manufacturer’s instructions.
PCR amplification was performed with the following
oligonucleotides: 50-GTCTGAGAGGGAGCCTTGTG-30
and 50-GCCAGCATCTGAGCCTTTAG-30 (from NCBI
acc #BC051137, nt 1303–2151). After linearization with
the appropriate enzyme and purification (PCR purifica-
tion Kit, QIAgen), two micrograms of DNA template
were used for the synthesis of radiolabeled transcript by
in vitro transcription with 35S-UTP (Amersham). After
20min of DNase I (Roche) treatment, the probe was
purified by the RNeasy Clean up protocol (QIAgen)
and measured in a scintillation counter. For in situ
hybridization, sections were dewaxed, pretreated and
prehybridized as described previously (22). Subsequently,
they were hybridized overnight with a probe concentration
of 7 107 c.p.m./ml at 578C and washed at 658C in
0.1 SSC and 0.1mM DTT. The hybridized slides were
dipped in autoradiographic emulsion (Kodak, NTB2),
developed after 3 weeks, counterstained with cresyl violet,
dehydrated in an ascending ethanol scale and Xylol, and
lidded with DPX. Images were taken using an AxioCam
MRc camera and the AxioVision program (Carl Zeiss).
Detailed protocols for the preparation of radiolabeled
probes and ISH procedures are given at http://
www.empress.har.mrc.ac.uk/EMPReSS/servlet/EMPReSS.
Frameset.
Western blotting
Total protein was extracted from brain tissue. Tissue was
homogenized in RIPA buffer (50mM Tris-HCl pH 7.4,
1% NP-40, 0.25% sodium deoxycholate, 150mM NaCl,
1mM EDTA, protease inhibitor), sonificated and centri-
fuged. Fifty micrograms protein of each sample were run
on a 10% Tris-HCl gel (Biorad) and blotted on a PVDF
membrane (Pall). After blocking with 4% skim milk the
membrane was incubated with the first antibody (1–3 h),
washed with TBST, incubated with the second
horseradish-peroxidase-conjugated antibody (1 h) and
washed with TBST. The detection reaction was initiated
with ECL detection reagents (Amersham) and the
membrane was exposed to Hyperfilm (Amersham). For
quantification of band intensities ECL plus was used
instead of ECL detection reagent and chemifluorescent
bands were detected with the FLA-8000 fluorescent image
analyzer (Fujifilm Life Science). The antibodies used were
anti-b-ACTIN (AC-15, #ab6276, Abcam, 1 : 100 000, 1 h
incubation), anti-MEK1 (sc-219, Santa Cruz
Biotechnology, 1 : 1000, 1 h incubation), anti-MEK2
(#610235, BD Transduction Laboratories, 1:2500, 1 h
incubation) and anti-BRAF (sc-166, Santa Cruz
Biotechnology, 1 : 600, 3 h incubation).
RESULTS
Development of conditional shRNA vectors
To control the activity of shRNA vectors through Cre/
loxP mediated recombination, their transcription must
be initially aborted by a loxP flanked stop element. The
shRNA vector should be activated upon Cre mediated
deletion of the stop segment. Since a single 34 bp loxP site
remains in the activated vector after Cre recombination,
we first tested whether this additional sequence disturbs
RNAi efficiency. Therefore, we used vector configurations
with different positions for the remaining loxP site, where
the shRNA is driven by the human U6 or H1 promoter
(Figure 1A and B). We found that the loxP site in all
configurations of H1 promoter driven constructs strongly
diminished the efficiency of gene silencing whereas the
loxP site in all constructs driven by the U6 promoter did
not significantly affect RNAi-mediated gene silencing
(Figure 1C). Thus, the U6 but not the H1 promoter is of
use for Cre mediated control of shRNA expression and we
chose the loxP5 configuration (Figure 1A) as one effective
configuration that includes the loxP sequence within the
loop region.
According to this design we inserted a loxP-flanked
270 bp DNA segment, which includes termination
sequences and serves as transcriptional stop element, in
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our parental U6 driven shRNA vector. The presence of
the stop element in the ‘off ’ configuration of the
conditional shRNA vector allows only the transcription
of the sense region that does not induce RNA interference,
provided that the shRNA construct follows the order
50-sense-loop-antisense-30 (Figure 2A). Upon Cre
mediated deletion of the stop cassette, the shRNA
vector acquires the configuration of loxP5 with the
remaining loxP site in the loop sequence. To assess the
functionality of the stop element, it was first inserted into
the loop region of U6-shRNA vectors against the
b-Galactosidase or F-Luciferase reporter genes
(Figure 2A). Upon transient cotransfection with reporter
gene expression plasmids into mouse ES cells,
the efficiency of the stop cassette in the ‘off ’ state and
RNAi efficiency in the ‘on’ state were analyzed and
compared to the non-modified parental vectors U6-shLuc
and U6-shLacZ (Figure 2B). The measurement of
F-Luciferase and b-Galactosidase activity from trans-
fected cells showed that the ‘off ’ versions did not induce
gene silencing whereas the ‘on’ versions induced the same
level of RNAi as the parental, non-conditional vectors
(Figure 2B). These results show that the stop element and
our loxP5 configuration provide a way to control shRNA
expression through Cre mediated recombination.
Single copy shRNA expression from the Rosa26 locus
For the genomic integration of conditional shRNA
vectors, a single-copy approach is preferable since multi
copy integrations could undergo unpredictable and non-
functional rearrangements upon Cre mediated recombina-
tion. We tested the efficiency of a single shRNA vector
copy in the Rosa26 locus (15) of murine ES cells with
b-Galactosidase as reporter gene. We first inserted a splice
acceptor sequence and the b-Galactosidase coding region
by gene targeting downstream of the first exon of one
Rosa26 allele of murine ES cells. These modified R26.5 ES
cells express b-Galactosidase from the endogenous,
ubiquitously active Rosa26 promoter. Next, the second
Rosa26 allele of R26.5 ES cells was targeted with a single
Figure 1. RNAi activity of H1 or U6 promoter based shRNA expression vectors modified by loxP sites. (A) Overview of the tested shRNA vectors.
The position of the loxP sites (red triangle) in relation to the start of transcription (black arrow) and the shRNA region (blue arrows) are indicated.
In the resulting shRNAs loxP derived sequences are shown in red color. All constructs contain identical sense and antisense shRNA sequences with
specificity to b-Galactosidase (lacZ). (B) Sequences of the H1 and U6 promoter constructs. The different positions of the loxP and lox2272 sites (red),
respectively, within or outside of the promoter are shown. The nucleotide of the transcriptional start is highlighted in gray. In capital letters:
TATA box of the promoter; bold: original loop region and in blue and underlined: shRNA sense and antisense regions. (C) Silencing activity of
b-Galactosidase specific shRNA vectors upon transient cotransfection with b-Galactosidase and F-Luciferase expression plasmids into ES cells.
Values are expressed as ratio of b-Galactosidase to Luciferase activity in RLU in comparison to the positive control. The results obtained with the
parental shRNA vectors H1-shLacZ and U6-shLacZ are shown as black columns. Numbers above the columns indicate the efficiency of silencing of
b-Galactosidase activity in percent in comparison to the positive control. All results from duplicate samples are expressed as mean values with
standard deviation.
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copy of the conditional shRNA vector U6-lox-lox-shLacZ
giving rise to R26.5/R26.9 ES cells. In the double-targeted
R26.5/R26.9 cells, the shRNA vector stop cassette was
deleted by transient transfection with a Cre expression
plasmid (Figure 3A). Three ES cell clones harboring the
non-activated and two clones carrying the recombined
shRNA construct (R26.5/R26.9 cells) were isolated and
analyzed for b-Galactosidase activity by histochemical
staining (X-Gal) and by a chemiluminescence assay using
cell lysates. X-Gal staining revealed a strong reduction
of b-Galactosidase activity in R26.5/R26.9 ES cells
as compared to non-recombined R26.5/R26.9 cells
(Figure 3B). The quantitative analysis revealed that the
b-Galactosidase activity in R26.5/R26.9 cells is reduced
by 90% (Figure 3C). Thus, a single genomic shRNA
vector copy within the Rosa26 locus is sufficient to induce
RNAi in ES cells and the extent of gene silencing can
reach a similar level as obtained by transient transfections
(compare to Figure 2B).
To facilitate the insertion of shRNA vectors into the
Rosa26 locus of ES cells for the fast generation of multiple
knockdown mouse lines, we developed an approach for
recombinase mediated cassette exchange (RMCE) using
the integrase of phage fC31 (C31Int). For this purpose,
ES cells with a Rosa26 acceptor allele were generated.
These cells harbor a pgk promoter driven hygromycin
resistance gene, of which the coding and polyA region
Figure 2. Cre/loxP controlled conditional shRNA vectors. (A)
Scheme for the modification of an shRNA vector into a Cre/loxP
controlled version by insertion of a loxP flanked stop cassette into the
shRNA loop region. The conditional shRNA vector can be activated
by excision of the stop cassette through Cre mediated deletion. A single
loxP site remains within the shRNA loop. (B) Transient transfection of
b-Galactosidase (lacZ, blue columns) or F-Luciferase (Luc, orange
columns) specific conditional shRNA vectors before (U6-lox-lox-shLuc;
U6-lox-lox-shLacZ) and after excision of the loxP flanked stop cassette
(U6-loxP5-shLuc; U6-loxP5-shLacZ) into ES cells. For F-Luciferase
shRNA vectors values are expressed as ratio of Luciferase to
b-Galactosidase activity (left Y axis) and for b-Galactosidase shRNA
vectors as ratio of b-Galactosidase to Luciferase activity (right Y axis),
in comparison to the appropriate positive control. Results are expressed
as mean values from duplicate samples with SD. U6-shLuc,
U6-shLacZ: parental shRNA vectors; RLU: relative light units.
Figure 3. Cre mediated activation of a single copy conditional shRNA
vector within the Rosa26 locus of murine ES cells. (A) One Rosa26
allele of ES cells was modified by a gene-targeting vector (R26.5) that
introduced a splice acceptor-lacZ cassette and a hygromycin resistance
gene such that b-Galactosidase (lacZ) is expressed from the endogenous
Rosa26 promoter. R26.5 ES cells were further modified with a gene
targeting vector (R26.9) that introduced a neomycin resistance gene and
the conditional shRNA vector U6-lox-lox-shLacZ. The R26.5/R26.9 ES
cells were transiently transfected with a Cre expression vector and
subclones that recombined the R26.9 allele (R26.9) were isolated.
(B) X-Gal staining of fixed R26.5/R26.9 ES cells in comparison to a
R26.5/R26.9 clone shows highly reduced b-Galactosidase activity in
the latter cells (magnification 20). (C) Comparison of b-Galactosidase
activity in lysates of R26.5/R26.9 ES cells (mean of three non-deleted
subclones, blue column) in comparison to two deleted subclones
(R26.9-1, R26.9-2, red columns) and wild type ES cells (WT).
Values are shown as b-Galactosidase activity in RLU per micrograms
protein of the lysates in comparison to the non-deleted clones and are
expressed as mean values with SD.
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is flanked by attP recognition sites, in the Rosa26 locus
(Figure 4B). The acceptor allele is designed such that the
attP-flanked segment can be replaced by an attB-flanked
construct from a donor plasmid (pRMCE) upon transfec-
tion of ES cells together with a C31Int expression plasmid
(Figure 4A). The donor vector contains a promoterless
neomycin resistance coding and polyA region and the
shRNA expression cassette between the attB recognition
sites. The shift from hygromycin to neomycin resistance in
ES cells selects for RMCE events (Figure 4C), such that
correct cassette exchange occurs at a frequency of 40–60%
among the neomycin resistant ES cell colonies (data not
shown).
Conditional Braf andMek1/2 shRNAmice
To study the effects of RNA interference against
components of the MAPK cascade in vivo, we generated
two conditional knockdown mouse lines. For the first
mouse line, shBraf-flox, expressing an shRNA against
Braf, we generated six shRNA vectors and tested their
knockdown efficiency by transient transfection in cell
culture (data not shown). In the vector containing the
most efficient shRNA sequence, we inserted the stop
cassette to block shRNA transcription before Cre
recombination (pbs-U6-shBraf-flox). The shRNA expres-
sion cassette of this vector was in turn inserted into the
donor vector pRMCE to generate recombinant ES cells
via RMCE (Figure 4A).
The second mouse line, shMek-flox, was generated in
the same way as shBraf-flox. The shRNA sequence was
chosen in a way that it targets Mek1 as well as Mek2,
in a region where both mRNAs show 100% homology
(in Exon 2 of both genes). Due to the restricted targeting
region, here only two different shRNA vectors were
generated and tested for efficiency.
Recombinant ES cells were injected into blastocysts to
generate shBraf-flox and shMek-flox mice. Upon germline
transmission, heterozygous shBraf+/flox mice were crossed
to CamKII-cre mice to activate RNAi in forebrain
neurons of adult mice (20). Mice carrying one modified
Rosa26 allele with the shMek-flox construct were crossed
to Nestin-cre mice, which express Cre recombinase in
neuronal and glia cell precursors, to activate RNAi in the
nervous system (21). All animals, containing the condi-
tional shRNA construct or the activated shRNA together
with the Cre transgene, were viable, fertile and showed no
obvious phenotype.
Analysis of knockdown in shBraf-flox mice
Cre recombinase under the CamKII promoter activates
the shRNA only in neurons of the adult forebrain (20).
To show the deletion of the stop cassette in the U6-shBraf-
flox element, a Southern blot analysis with genomic DNA
from different brain regions was performed. A shift of the
5.4 kb band with the stop cassette to an 8.6 kb band after
Cre recombination indicates activation of RNAi
(Figure 5A). This larger band is visible only in forebrain
regions of mutant mice, like the olfactory bulb, the
hippocampus, striatum, cortex and very weak in the
thalamus, but not in more posterior parts of the brain of
these mice or in control mice. As expected, the 5.4 kb band
from the inactive shRNA allele is still visible in all the
Figure 4. Vector construction and RMCE for the generation of shBraf-flox and shMek-flox mice. (A) The conditional shRNA expression cassette
from the vector pbs-U6-shRNA-flox contains the U6 promoter in front of the sense (s) sequence of the shRNA, the loxP (lox) flanked stop cassette
in the loop region and the antisense (as) shRNA sequence. The shRNA expression cassette is cloned into the RMCE donor vector pRMCE behind
the promoterless neomycin selection marker (neo-bpA) so that the two attB sites from pRMCE flank the selection marker as well as the shRNA
expression cassette. (B) Acceptor ES cells for RMCE harbor a Rosa26 allele where in intron 1 a splice acceptor (SA) is inserted followed by a pgk
promoter (pgk) driving a hygromycin selection marker (hygro-bpA) which is flanked by attP sites. (C) Upon RMCE with C31Int, the attP flanked
cassette in the acceptor ES cells from B is replaced by the attB flanked cassette from the donor vector in A. FRT (f) sites allow to excise the pgk
promoter and the neomycin marker in recombined ES cells or mice. E: EcoRV; B: BamHI; probe: 50-Rosa26 probe and E1: exon 1.
e90 Nucleic Acids Research, 2007, Vol. 35, No. 12 PAGE 8 OF 12
 at FA
K
/M
D
C on M
ay 28, 2014
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
forebrain regions of mutant mice, resulting from non-
neuronal cells in the forebrain expressing no Cre
recombinase.
Consistent with the situation on the genomic level, we
could show expression of the Braf shRNA in mutant mice,
but not in control mice without Cre transgene, on a
Northern blot with short RNAs (Figure 5B). At the
protein level, reduction of BRAF protein is visible in brain
regions of mutant mice where Cre recombination occurred
(Figure 5C). Slight protein knockdown of BRAF in
midbrain and cerebellum, where no Cre recombination on
the DNA level is visible, may be due to recombination in a
small fraction of cells that remains undetected by
Southern blot analysis (Figure 5A). Since the BRAF
expression in these regions is low and restricted (23), the
limited Cre activity could still result in visible protein
knockdown if a substantial fraction of Braf expressing
neurons also coexpress Cre recombinase. No protein
knockdown is visible in the brainstem. Estimation of levels
of protein reduction in forebrain regions revealed a
knockdown of 70% compared to protein expression in
control mice.
Analysis of knockdown in shMek-flox mice
In contrast to the CamKII promoter, the Nestin promoter
drives the expression of Cre recombinase in all nervous
tissue (21). To show the deletion of the stop cassette from
the U6-shMek-flox vector in the whole brain of adult
mice, a Southern blot was performed in the same way as
for the shBraf-flox mice. Also here the band from the
shRNA allele is shifted from 5.4 kb with the stop cassette
to 8.6 kb after Cre recombination (Figure 6A). The larger
band is visible in all brain regions of mutant mice, but not
in control mice. The 5.4 kb band from the inactive shRNA
allele is absent in all brain regions from mutant mice,
indicating complete Cre mediated recombination and
therefore shRNA activation in the whole adult brain.
Hence, we could show high expression of the shMek
transcript in mutant mice but not in control mice on a
Northern blot with short RNAs from whole brains
(Figure 6B).
Figure 5. Analysis of RNA interference in shBraf+/flox/CamKII-cre
mice. (A) Tissue-specific activation of shRNA in the brain with
CamKII-cre. Southern blot analysis of BamHI digested genomic DNA
from different brain regions of adult shBraf+/flox/CamKII-cre mice.
Lane 1: DNA from whole brains of shBraf+/flox control mice; lane
2–10: DNA from indicated regions of shBraf+/flox/CamKII-cre mice.
The wild type Rosa26 allele (wt) gives a 5.8 kb band and the band from
the shRNA allele is shifted from 5.4 kb with the stop cassette (flox) to
8.6 kb after Cre recombination (del). (B) Expression of shRNA against
Braf in adult forebrain. On a Northern blot with small RNAs against
the sequence of shBraf the 21 nt band of the processed siRNA
against Braf is only detectable with the control oligonucleotide and in
mutant mice but not in control mice. (C) BRAF protein reduction in
forebrain regions of shBraf+/flox/CamKII-cre mice. On a Western blot
with protein from the indicated brain regions from adult mouse brain,
knockdown of BRAF protein in forebrain regions of mutant mice is
shown in comparison to the protein level from control mice. b-ACTIN
was used as a loading control. OB: olfactory bulb, HC: hippocampus,
St: Striatum, fCx: frontal cortex, pCx: posterior cortex, Th: Thalamus,
MB: midbrain, CB: cerebellum, BS: brainstem, +/flox: shBraf+/flox and
+/: shBraf+/flox/CamKII-cre.
Figure 6. Analysis of RNA interference in shMek+/flox/Nestin-cre mice.
(A) Tissue specific activation of shRNA in the brain with Nestin-cre.
Southern blot analysis of BamHI digested genomic DNA from different
brain regions of adult shMek+/flox/Nestin-cre mice. Lane 1: DNA from
whole brains of shMek+/flox control mice; lane 2–10: DNA from
indicated regions of shMek+/flox/Nestin-cre mice. The wild type Rosa26
allele (wt) gives a 5.8 kb band and the band from the shRNA allele is
shifted from 5.4 kb with the stop cassette (flox) to 8.6 kb after Cre
recombination (del). (B) Expression of shRNA against Mek1 and Mek2
in whole adult brain. On a Northern blot with small RNAs against the
sequence of shMek the 23 nt band of the processed siRNA against
Mek1 and Mek2 is highly detectable with the control oligonucleotide
and in mutant mice but not in control mice. (C–E) Knockdown of
Mek1 mRNA. On a Northern blot of total RNA from whole adult
brain (C) Mek1 mRNA from mutant mice is decreased 65%
compared to control mice. -Actin was used as a loading control.
In situ hybridization against Mek1 mRNA on coronal brain sections
shows the knockdown effect throughout the brain of mutant mice (E)
in contrast to the high wildtype expression of Mek1 mRNA in control
mice (D). (F) MEK1 and MEK2 protein reduction in the brain of
shMek+/flox/Nestin-cre mice. On a Western blot with protein from the
indicated regions from adult brain, knockdown of MEK1 and MEK2
in mutant mice is shown in comparison to control mice. b-ACTIN was
used as a loading control. OB: olfactory bulb, HC: hippocampus, St:
Striatum, fCx: frontal cortex, pCx: posterior cortex, Th: Thalamus,
MB: midbrain, CB: cerebellum, BS: brainstem, Cx: cortex, Amy:
amygdala, Hy: hypothalamus, +/flox: shMek+/flox, +/: shMek+/flox/
Nestin-cre; scale bar in D and E: 1mm.
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Since the shRNA of these mice is specific for bothMek1
and Mek2 mRNA, knockdown should occur at the
mRNA and protein level of both genes. But due to the
very low expression level of Mek2 mRNA in the adult
brain (23), detection of mRNA is possible only for Mek1
(Figure 6C). Quantification of the Northern signal
revealed a 65% reduction of mRNA in mutant brains as
compared to wild type controls. In situ the reduction of
Mek1 mRNA can be observed in the whole brain of
mutant mice compared to control mice (Figure 6D and E).
On the protein level, reduction of MEK1 and MEK2
protein was observed in the whole brain of mutant mice
(Figure 6F). Estimation of levels of protein reduction
revealed a knockdown of about 65% for MEK1—
consistent with the mRNA knockdown—and 50% for
MEK2 compared to control expression each.
DISCUSSION
Here, we describe a novel technique to inactivate one or
two related genes in the adult murine brain with RNA
interference in a tissue-specific manner. We developed
conditional shRNA expression vectors that can be
activated upon Cre mediated recombination. After testing
various configurations for the positional effect of a
transcriptional stop cassette within H1 or U6 promoter
driven shRNA vectors, we selected one construct with
high knockdown efficiency after Cre recombination. Due
to the position of the stop cassette, the loop region of the
shRNA transcribed from this expression construct is
elongated by 34 nt. In contrast to former studies asserting
a 9 nt loop sequence being the most efficient configuration
(24), our elongated loop sequence does not interfere with
shRNA efficiency. Essential for this technique, we could
show that the insertion of a loxP flanked stop segment into
the loop region of shRNA vectors disrupts RNAi
induction and that such vectors can be activated through
Cre mediated recombination.
An obvious application for conditional RNAi are
shRNA vector transgenic mice since a large collection of
mouse strains that express Cre recombinase in specific cell
types is available and can be used to activate conditional
shRNA in different developmental stages and cell types
(7). For the genomic integration of such expression
vectors, different approaches are available (25).
Transgenic RNAi mice have been generated by pronuclear
injection (26–28), by lentiviral infection (29) or electro-
poration of ES cells (3). All these approaches result in
random, multicopy integrants of the shRNA vector and
therefore require a laborious analysis of multiple lines due
to the influence of the genomic environment and the
vector copy number on transgene expression (3,27). Apart
from the time and resources needed for this initial
screening of mouse lines, it is not applicable to conditional
shRNA vectors since multicopy integrations could
undergo unpredictable and non-functional rearrange-
ments through Cre mediated recombination. Hence,
a single-copy approach using a defined and well-
characterized genomic locus is preferable.
The HPRT and the Rosa26 locus are frequently used
for the genomic integration of expression vectors and have
also been used for shRNA vectors (30–32). Since the
HPRT locus is affected by X-inactivation in female mice,
we chose the Rosa26 locus for integration of our shRNA
vectors. Using a reporter gene, we showed in homologous
recombinant ES cells that our conditional shRNA
expressed from one vector copy in the Rosa26 locus
gives rise to highly efficient gene knockdown after Cre
mediated recombination, comparable to transient trans-
fections of multiple vector copies. Thus, the Rosa26 locus
allows effective and reproducible U6 promoter driven
transcription of shRNA and the amount of shRNA
transcribed from one single vector integrant is sufficient
for efficient gene knockdown. The functionality of the U6
promoter within a defined chromosomal locus, like
Rosa26, lays the basis for conditional RNAi in mice
using a single vector copy that is recombined by Cre
recombinase into a single, predictable product.
To circumvent the laborious and inefficient homologous
recombination step for mouse generation, we further used
RMCE to produce ES cells harboring one copy of the
shRNA expression vector in the Rosa26 locus. With this
approach, the frequency of properly recombined ES cell
clones among selection positive clones rises from 1%
with homologous recombination at Rosa26 to 40–60%
with RMCE.
Our RNAi mice generated with these techniques harbor
a conditional shRNA vector either against Braf or Mek1
and Mek2 at once. These mice are viable, fertile, show no
overt phenotype, and do not express the specific shRNA
before Cre mediated recombination. We used two different
Cre expressing mouse lines—both expressing Cre recom-
binase in a brain-specific manner—to activate shRNA
transcription. We showed that in shBraf+/flox/CamKII-cre
mice Cre mediated recombination occurs only in neurons
of forebrain regions of the adult brain and in shMek+/flox/
Nestin-cre mice in all cells of the adult brain, as described
previously (20,21). Consequently, shRNA expression and
reduction of mRNA and protein is detectable in these
tissues from mice expressing Cre recombinase. The extent
of specific mRNA and protein knockdown reaches 70%
in case of Braf andMek1 and 50% forMek2. Important
to mention here is, that shMek+/flox/Nestin-cre mice
produce one shRNA targeting Mek1 and Mek2 at once.
Although the efficiency of RNAi is not identical for both
genes, we show that it is feasible to knockdown several
related genes simultaneously.
So, this technique will facilitate functional studies of
gene families where the loss of one gene may be com-
pensated by other familymembers (33,34). Addressing such
questions with conventional knockout strategies implies an
enormous effort of breeding and genotyping to obtain
double or even triple knockout animals. With RNAi,
generating multiple knockdown mice is not more effort as
compared to single knockdown mice. Furthermore, the
production of shRNA expressing mice is much faster and
easier than that of knockout mice, especially with the use of
RMCE. Thus, in 3–4 months even conditional knockdown
mice can be generated whereas at least 12 months are
required for the production of a classical unconditional
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knockout strain. Moreover, the effort of breeding shRNA
mice is significantly decreased since only one shRNA allele
is required to exert the knockdown of the targeted gene and
breeding for homozygosity (as for knockout mice) is not
required.
In the conditional shRNA mice against MAPKs
reported here, we reached knockdown levels of up to
70% after Cre mediated recombination. In the reporter
gene experiments, we showed that in ES cells a higher
knockdown level of up to 90% is possible with the single-
copy approach in the Rosa26 locus. Using shRNAs
against the CRHR1 (corticotropin releasing hormone
receptor 1) and LRRK2 (leucine-rich repeat kinase 2)
genes we indeed obtained knockdown efficiencies of 80
and 90%, respectively, in the adult brain (R. Ku¨hn,
unpublished data). Therefore, the level of knockdown that
can be reached in vivo with the Rosa26-shRNA approach
is not limited to 70% but rather depends on the intrinsic
efficacy of the specific target sequence of an individual
shRNA, able to elicit either higher or lower levels of gene
silencing. Using public available siRNA prediction pro-
grams as paradigm for the design of five shRNA vectors
for each gene, we usually find one vector that induces
in vitro a knockdown of 90%. This average efficiency
should improve in future with the further development of
siRNA and shRNA prediction algorithms. To obtain
higher knockdown levels for Braf and Mek1/2 the
selection of new, more efficient shRNA sequences would
be necessary. Another possibility to enhance the efficiency
of less potent shRNA sequences may be to increase the
number of active siRNAs in the cell. To test whether
increased shRNA levels result in improved knockdown,
we compared the residual target gene expression in single
copy heterozygous and double copy homozygous shRNA
mice. In the three tested mouse lines we found in
homozygous shRNA mice a moderate (5–10%) but
not dramatic increase of knockdown efficiency (C. Hitz, P.
Steuber-Buchberger, unpublished data). But even a less
potent protein knockdown can result in a phenotype
giving interesting insights to the mode of function of the
gene. For example Shalin et al. (35) showed impaired fear
conditioning in mice with a 40% reduction in ERK1/2
activation. Furthermore, constitutive knockdown with
our shRNA against Mek1/2, indeed, does not lead to a
placental defect as described for the constitutive knockout
ofMek1 (36), but it leads to dwarfism and death at the age
of 6 weeks (data not shown). All in all, the doubling of the
shRNA copy number and the use of different shRNA
target sequences offer the option to exploit differences in
efficiency of shRNA sequences to produce allelic series as
refined models of genetic diseases beyond the ‘all or
nothing’ principle of knockout mice (37).
We demonstrate that RNAi is a powerful tool for the
generation of conditional mouse mutants to study the
function of single or related genes in vivo. Recently, Seibler
et al. (38) described a new approach for conditional RNAi
using the tetO/tetR system. In contrast to our cell type-
specific Cre/loxP regulated system the tetR regulated
system is reversible and can be switched on and off
optionally. However, the tetO/tetR system is not cell type
specific and acts simultaneously in all organs and cell
types. Since more than 150 strains of tissue specific Cre
transgenic mice are available, we expect that our condi-
tional shRNA approach can be applied to a wide range of
biological questions in a variety of tissues. Here, we used
this approach to generate brain-specific knockdown mice
for members of the MAPK pathway to gain insight into
the function of this signaling cascade that has been
proposed to play a role in mood disorders (10). In a first
behavioral characterization of Mek1/2 knockdown mice,
we observed a contribution of these kinases to the
expression of exploratory and anxiety related behavior
(data not shown). Further, more detailed studies using
conditional knockdown mice are in progress to establish
the relation of this phenotype to human anxiety disorders.
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